As shown in Figure 3 and Supplementary Figure S1, our findings indicated that increased levels of RBFOX2 corresponded to unfavorable OS outcomes in multiple cancer types including ACC, BLCA, CESC, HNSC, KICH, LAMI, LUAD, MESO, OV, PAAD, SARC, STAD, THCA, THYM, UCEC, and UVM. Here, RBFOX2 is linked to cancer.